Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Urinary Bladder Neoplasms × Synapsins × 90 days × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Urinary Bladder Neoplasms 1

Interventions

Gemcitabine 26 pembrolizumab 19 Cisplatin 19 Specimen Handling 15 Magnetic Resonance Spectroscopy 15 durvalumab 10 Nivolumab 9 enfortumab vedotin 8 avelumab 8 atezolizumab 7 Carboplatin 7 Mitomycin 6 Docetaxel 6 Cystoscopy 6 Cystectomy 6 Radiation 5 Paclitaxel 5 Biopsy 5 sacituzumab govitecan 4 Transurethral Resection of Bladder 4 Standard of Care 4 Radiotherapy 4 Ipilimumab 4 Fluorouracil 4 erdafitinib 3 dehydroftorafur 3 cabozantinib 3 Practice Guidelines as Topic 3 Platinum 3 Mitozytrex 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07332351 2026-03-13

TRIFECTA

University of Washington

Phase 2 Not yet recruiting

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡